U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844356) titled 'The Safety and Efficacy of HR19034 in Children With Myopia' on Sept. 22.
Brief Summary: The study is being conducted to evaluate the efficacy, and safety of HR19034 Eye Drops. To explore the reasonable dosage of HR19034 for slowing the progression of myopia in children
Study Start Date: Oct. 14, 2021
Study Type: INTERVENTIONAL
Condition:
Slowing the Progression of Myopia in Children
Intervention:
DRUG: HR19034
HR19034 Dose 1
DRUG: HR19034
HR19034 Dose 2
DRUG: Placebo
Placebo
Recruitment Status: COMPLETED
Sponsor: Chengdu Suncadia Medicine Co., Ltd.
Published by HT Digital Content Services with permission from Health D...